Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Liver Cancer
Tampa General Hospital’s Liver Oncology Program is pleased to provide many of the latest breakthroughs in liver cancer therapies to patients. One such treatment is hyperthermic intraperitoneal chemotherapy (HIPEC).
How Does HIPEC Work?
Hyperthermic intraperitoneal chemotherapy uses cancer-fighting drugs to attack liver cancer. Unlike traditional forms of chemotherapy that are administered orally or intravenously, it is heated to increase potency and delivered directly into the abdominal cavity. Because hyperthermic intraperitoneal chemotherapy is given alongside surgery to remove tumors, a surgeon can ensure it is appropriately applied to all affected structures. It is also associated with fewer and less severe side effects than traditional chemotherapy.
Am I a Candidate for HIPEC?
Liver cancer is a complex disease that requires highly individualized treatment. Only a cancer specialist can determine what therapies are best for each patient. In general, though, hyperthermic intraperitoneal chemotherapy may be considered for patients whose liver cancer has spread to other organs in the abdominal region, such as the stomach or colon, but has not entered the bloodstream. It may also be a viable treatment option for patients with tumors that are inoperable or cannot be completely removed through surgery.
If you’d like to learn more about hyperthermic peritoneal chemotherapy and our approach to liver cancer treatment, consider scheduling an appointment at TGH by calling (813) 844-5480. You can also contact us for a second opinion or to discuss potential liver cancer symptoms with a specialist. Our team prioritizes prompt response times and will schedule your appointment as quickly as possible.